What to expect: Same active ingredient (tirzepatide), different manufacturing. Transition to equivalent dose. Verify Zepbound formulary status before switching.
Washout window: None — same active ingredient
Why patients switch from Compounded tirzepatide to Zepbound
- FDA removed tirzepatide from shortage list (October 2024) — 503A/503B compounders must wind down
- Insurance now covering Zepbound for obesity indication
- FDA-approved finished product offers full regulatory oversight
- Brand consistency in dose + sterility
- 503A compounding pharmacies facing enforcement letters from FDA
Side effects during the Compounded tirzepatide → Zepbound transition
- Typically none — same molecule
- Possible injection site differences (Zepbound vial vs compounded syringe)
- Brief GI re-adjustment if dose stepped up
Discuss with your prescriber before switching
This guide is editorial — not medical advice. Switching GLP-1 medications must be supervised. Bring this checklist to your appointment:
- Required — confirm Zepbound prior authorization approval
- If BMI < 30 and no comorbidity, Zepbound may not be covered
- Discuss whether single-dose vials or autoinjector pen suits you
Dose conversion: Compounded tirzepatide → Zepbound
Use this table as a starting reference only. Final dose depends on your tolerance, weight-loss trajectory, and prescriber guidance. Never self-titrate based on a chart.
| Compounded tirzepatide dose | Zepbound dose | Note |
|---|---|---|
| 0.25 mg/week | 0.25 mg/week | Starting dose — identical |
| 0.5 mg/week | 0.5 mg/week | — |
| 1 mg/week | 1 mg/week | — |
| 1.7 mg/week | 1.7 mg/week (Wegovy only) | — |
| 2 mg/week | 2.4 mg/week (Wegovy max) | — |
Transition timeline
Plan on 2-week prep + 12-week evaluation window. Most weight-loss outcomes can be re-assessed at the 12-week mark on the new medication.
Week −2: Decision + prescriber alignment
Confirm with your prescriber: dose-equivalent target, expected side-effect profile differences (tirzepatide → tirzepatide), insurance implications.
Week −1: Last Compounded tirzepatide dose
Continue your current Compounded tirzepatide schedule. Compounded tirzepatide has a long half-life — semaglutide ~1 week, tirzepatide ~5 days — so effects persist for days after stopping.
Week 0: First Zepbound dose
Start Zepbound at your equivalent dose (see table below). Combined effect may be elevated in the first week as Compounded tirzepatide clears.
Weeks 1-4: Stabilization
Side-effect profile shifts. GI symptoms (nausea, constipation) may be more pronounced. Track weight + appetite.
Weeks 4-12: Re-evaluation
Compare outcomes to your Compounded tirzepatide baseline. If weight-loss trajectory hasn't improved by week 12, discuss whether the switch was right.
Beyond 12 weeks
If outcomes good, continue. If switch underperformed Compounded tirzepatide, discuss reverting or trying a third option (often semaglutide-based).
FAQ — Compounded tirzepatide → Zepbound
Can I take Compounded tirzepatide and Zepbound together?
No. Both contain tirzepatide — taking them together is effectively double-dosing the same medication. Stop Compounded tirzepatide before starting Zepbound.
Will I lose ground when switching from Compounded tirzepatide to Zepbound?
Possibly temporarily. Most patients maintain weight during a clean switch when restart dose is appropriate. The bigger risk is regression if the switch fails to match Compounded tirzepatide efficacy. Plan and 12-week evaluation window.
Does insurance cover Zepbound if it covered Compounded tirzepatide?
Zepbound is FDA-approved — insurance coverage is more typical. Verify formulary status and whether prior authorization is required for Zepbound specifically.
How long does Compounded tirzepatide stay in my system after the last dose?
Tirzepatide has a ~5-day half-life — effects taper over 3-4 weeks after the last injection.
Cost comparison
Cash-pay pricing differs significantly between Compounded tirzepatide and Zepbound. Run the true-cost calculator with your insurance details for an apples-to-apples comparison including coupons and patient assistance programs. Open true cost calculator →
Provider match
Find a provider that offers Zepbound
Continuity of care matters during a switch. We compared 12+ telehealth providers ranked by Zepbound availability, price, and prescriber accessibility.
See top Zepbound providers →Affiliate disclosure: we earn commission on provider sign-ups. Learn more
Next steps
Before switching, read our full Compounded tirzepatide review and Zepbound review. For provider options that carry both medications, see our Compounded tirzepatide vs Zepbound comparison and Compounded tirzepatide alternatives hub.
Sources
Not medical advice. Switching GLP-1 medications must be done with prescriber supervision. This guide is editorial summary based on published prescribing information and clinical guidance. Full medical disclaimer.